CureSkin
PrivateLast Round
Series B
Mar 13, 2024
Total Funding Raised
$26.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CureSkin operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Series B round in March 2024.
CureSkin is a health care technology company that provides an AI-powered dermatology platform offering personalized skincare and haircare treatment plans, dermatologist consultations, and home-delivered care products.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Medical AI, Fashion & Beauty, Personalization
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureSkin Comparables
Compare CureSkin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Traya | 82% | |
| MDalgorithms | 77% | |
| Clinikally | 77% |
For institutional investors. Book with your work email.
CureSkin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 13, 2024 | ||||
| Series A | Mar 7, 2022 | ||||
| Seed | Jan 28, 2020 | ||||
| Seed | Aug 22, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CureSkin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed, Series B |
| Taver Capital Partners | Seed |
| SenseAI | Series A |
| Sharrp Ventures | Series A, Series B |
| Y Combinator | Seed |
| SenseAI Ventures | Series A, Seed |
| Heartbeat Labs | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 89% MoM, reaching 70.7K.
- Jun 20, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_lossOct 29, 2026
Cureskin cuts its FY26 net loss to $3.69M, equivalent to Rs 35 crore, in Karnataka.
- has_revenueOct 29, 2026
Cureskin reports total revenue of Rs 134 crore in FY26, compared with $11.4M in the previous fiscal year, in India.
- has_revenueOct 29, 2026
Cureskin records $14M in revenue from operations in FY26, with product sales contributing approximately 91% of operating revenue in India.
For institutional investors. Book with your work email.
CureSkin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CureSkin's valuation, stock price, and market status.
Is CureSkin a public or private company?
CureSkin is a private company.
What is the current stock price of CureSkin?
CureSkin is a private company, so its shares have no public market price. Caplight tracks CureSkin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CureSkin worth (valuation)?
Valuation information for CureSkin is not publicly available.
Can I buy CureSkin stock?
CureSkin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CureSkin's last funding round?
CureSkin's most recent funding round was Series B on March 13, 2024.
Who are the main investors in CureSkin?
Key investors in CureSkin include SenseAI Ventures, HealthQuad, JSW Ventures.
Will CureSkin IPO soon?
No public IPO plans have been announced for CureSkin.
How can I track CureSkin secondary market activity?
Caplight tracks bids, offers, and trades in CureSkin's shares on secondary markets.